Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on CRVS stock, giving a Buy rating yesterday. Graig Suvannavejh’s rating is based on several compelling aspects of ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ZNTL stock, giving a Buy rating today. Tyler Van Buren has given his ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options ... AbbVie continues to ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...

When looking for biotech stocks to invest in ... now is the best time to buy before it’s too late. And the numbers speak for themselves: Amazon: if you invested $1,000 when we doubled down ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

In the wake of the presidential election, another change in interest rates and continued news about geopolitical unrest, the appeal of blue-chip stocks is stronger than ever. That' ...

This article highlights 10 affordable healthcare stocks that investors might consider adding to their portfolios. Each of ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...